The effectiveness of a warning label on carbonated beverage consumption for consumers with different habit strengths. by Yulian Ding (5984591)

Subjects:

The impact of a warning label on carbonated beverage consumption. by Yulian Ding (5984591)

Subjects:

Flow chart of the study. by Yulian Ding (5984591)

Subjects:

A sample choice question with a warning label. by Yulian Ding (5984591)

Subjects:

Consumption frequencies of different types of SSBs. by Yulian Ding (5984591)

Subjects:

Summary statistics of the sample. by Yulian Ding (5984591)

Subjects:

The impact of health knowledge and obesity status on the effectiveness of a warning label. by Yulian Ding (5984591)

Subjects:

Product attributes and attribute levels. by Yulian Ding (5984591)

Subjects:

Dataset used in this study. by Yulian Ding (5984591)

Subjects:

Socio-demographics of the subsamples with different habit strengths. by Yulian Ding (5984591)

Subjects:

Definitions of the variables. by Yulian Ding (5984591)

Subjects:

Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

The catalase enzyme response of <i>A</i>. <i>albopictus</i> larvae decreased (1.5-fold) in response to <i>M</i>. <i>robertsii</i>-derived copper nanoparticles. by Perumal Vivekanandhan (4863484)

Subjects:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease. by Emir Matpan (21655811)

“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”

ROC curves for hub genes. by Jiyong Zhang (2498740)

Subjects:

Differences in immune infiltration between NAFLD and control groups. by Jiyong Zhang (2498740)

Subjects:

Enrichment Analysis Based on Ferroptosis-Related Differentially Expressed Genes. by Jiyong Zhang (2498740)

Subjects: